Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ALFESS study of fixed-dose amlodipine + lisinopril in essential hypertension
2005-005749-20Phase 3Completed
- Sponsor
- Gedeon Richter Plc
- Start
- Jan 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of lisinopril + amlodipine and hydrochlorothiazide in essential hypertension, sponsored by Gedeon Richter Plc. Primary endpoints: Proportion achieving effective treatment, Office systolic blood pressure reduction and 1 more. Started Jan 2006; status: completed.
02
Drugs
lisinopril + amlodipinehydrochlorothiazide
03
Conditions
essential hypertension
Beyond the preview
Go deeper on 2005-005749-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-005749-20.